If you have psoriatic arthritis and work from home, its important to adjust your workspace to fit your needs. Pain and stiffness especially in the elbows and hands are common complaints, due to the repetitive motions involved in some office tasks and sitting in the same position all day. But making the right adjustments can help ease neck and lower back pain as well as joint pain and swelling that could otherwise make it hard to sit at a desk for hours.
An ergonomically correct workspace can help ease joint symptoms and reduce fatigue from spending extended periods of time in uncomfortable positions. Ergonomics is the science of fitting the task to the worker to maximize productivity while reducing discomfort, fatigue, and injury, says Natalia Ruiz, a physical therapist and certified office ergonomics evaluator with Rusk Rehabilitation at NYU Langone Health in New York City. Having an ergonomic setup ensures you work in neutral postures that reduce strain in your joints and tissues already affected by psoriatic arthritis. Therefore it can reduce your symptoms or reduce the risk of developing them [in the first place].
Proper support and good body mechanics can help prevent compensatory movement patterns that can lead to increased pain and stiffness, adds Jamie Hilker, an occupational therapist and certified hand therapist at Mayo Clinic in Rochester, Minnesota.
If you work a full-time job and require new equipment to make your home office more psoriatic arthritis friendly, talk to your employer. The Social Security Administration considers psoriatic arthritis a disability, and the Americans with Disabilities Act (ADA) requires employers to make reasonable accommodations that enable full-time employees to perform their essential job functions.
Reasonable accommodations may include physical changes to your workspace and accessible and assistive devices. That includes anything you need to be comfortable and productive at your job, such as special equipment you need. While these requirements dont always cover purchasing specific expensive equipment, your employer may be eligible for tax credits if they do supply you with accommodations.
In many cases, small adjustments to your workstation can make a big difference. Here are a few tips to help you set up a psoriatic arthritisfriendly home office.
An occupational or physical therapist who has knowledge in office ergonomics can help you design and modify your current home office space. These therapists specialize in adapting your environment to your abilities to help you better perform daily activities and reach your goals. They assess your particular setup, listen to your needs, and make recommendations based on observation and research, says Ruiz.
Hilker recommends looking for a licensed and registered occupational therapist or certified hand therapist. Ruiz suggests looking for a certified office ergonomics evaluator or board-certified practitioner of professional ergonomics.
To be covered by insurance, most evaluations require a doctors referral, says Hilker. Insurance typically covers some of the costs, but most people end up paying a portion [out of pocket], she says. Many corporate human resources departments will provide these services to their employees, Ruiz adds.
Your seated posture affects the positioning of your whole body. We can observe an increase in the stress on involved joints, such as the elbows, hands, knees, and feet when people sit in awkward positions, says Ruiz.
A comfortable chair is essential.Your workstation chair should:
Position your monitor directly in front of your face, with the top of the screen at or slightly below eye level. It should be about an arms length from you and directly behind your keyboard. (You may need to lower the monitor an inch or two if you wear bifocals).
Hilker says her psoriatic arthritis patients often say they struggle to find a comfortable position on a laptop. I often recommend getting a separate wireless keyboard in this case, she says. You can also buy an adjustable ergonomic laptop stand or a docking station with a full-size monitor to raise the height of your screen.
Your keyboard should be at a height where your elbows sit at or slightly more than 90 degrees while your wrists remain straight. If your keyboard is too high, you may want to either raise the height of your chair or buy a keyboard tray thats adjustable for both height and tilt and large enough to fit your keyboard and mouse on the same level.
Both Ruiz and Hilker recommend using an ergonomic split keyboard. It places the forearms and wrists in a more neutral position, says Hilker. She suggests trying out a few options at the store to figure out which feels most comfortable to you.
A keyboard rest may or may not keep your wrists in a more neutral position and prevent you from leaning your wrists on the edge of your desk. Just avoid mouse pads; Ruiz says theyre not great for your wrists and hands.
Once the rest of your body is in the correct position, check your feet: They should always remain firmly planted on the floor.
If your feet dont reach the ground when your chair is properly adjusted to your desk and computer equipment, place a footrest, small stool, or stack of books under your feet, suggests Ruiz.
Select a mouse that ensures your palm isnt completely flat, to avoid pressure on your wrist, suggests Ruiz. A vertical mouse (or any other mouse) that puts the hand in a slightly tilted position is a good bet.
It may also be easier for you to use a track pad instead of a mouse, as long as it reduces the stress in your hand and wrist. If you work in design, for example, where you have to constantly use a mouse, a trackpad can be a great option. If not, an ergonomic mouse can be used, says Ruiz. Some trackpads can be regulated to decrease the amount of pressure needed to activate and scroll, which can be helpful if joints are painful, adds Hilker.
Avoid any trackball mouse, Ruiz adds, since they tend to require too much motion in your thumb and fingers.
Keep objects you use a lot, such as your phone or stapler, within arms reach. If you cant comfortably reach something when youre sitting, stand up to get it.
Several other arthritis-approved assistive devices can reduce strain on the joints and help improve your symptoms and work performance, says Ruiz, including:
If you use the phone a lot for work especially if you have to take notes while talking use a headset or put your phone on speaker. This helps reduce stress in the neck and shoulders and keeps you from having to grip the phone in your hand or, worse, between your shoulder and ear.
Voice recognition apps and headsets can help decrease the amount of typing, says Hilker, which may also decrease pain.
Pay attention to your body throughout the day. If something feels tense or tight, get up, move, and stretch a bit.
Try to take a break and walk around your home or outside every 20 to 30 minutes. It doesnt have to be long: Two minutes is enough to reduce strain and get your blood flowing. Or Hilker suggests the 20-20-20 rule: Every 20 minutes, take a 20-second break and move 20 feet away from your workstation. Full-body movement is best, she says. Simply get up and walk around.
Add in a few gentle stretches that take just a minute or less. Focus on the areas that need it most: your neck, chest, lower back, forearms, and hips. Doing gentle shoulder rolls, neck movements, or low-back extensions can help reduce stiffness related to prolonged postures or repetitive motions, says Ruiz.
Sitting in awkward positions for long periods can lead to pain. For someone who has psoriatic arthritis, changing postures while working is very important to reduce stress to joints, muscles, ligaments, and tendons that can potentially generate pain, says Ruiz. Switching between sitting for 40 minutes and standing for 20 minutes is ideal, she says.
Sit-to-stand workstations are an excellent alternative to promote movement, adds Hilker.
Listen to your body, says Ruiz. Aim for comfort as much as possible, and plan ahead for rest periods during busy workdays.
Its also essential to keep work-related stress in check. Increased stress has been linked to increased pain level perception, says Ruiz. She recommends finding time for mindfulness activities, such as meditation, relaxation, and deep breathing exercises, during your day.
Continued here:
11 Ways to Make Your Home Office Psoriatic Arthritis Friendly - Everyday Health
- Guselkumab Demonstrates Significant Improvement in Psoriasis Symptoms and HRQoL, Reduces Sexual Impairment ... - Dermatology Times - April 18th, 2024 [April 18th, 2024]
- Psoriasis Patients with Arthralgia At Increased Risk of Psoriatic Arthritis Development - MD Magazine - April 18th, 2024 [April 18th, 2024]
- Diagnosing Psoriatic Arthritis for the Dermatologist: Guidance From the Experts - Medscape - April 18th, 2024 [April 18th, 2024]
- Secukinumab 300 mg May Improve PsA or Active Psoriasis More Than 150 mg - MD Magazine - April 18th, 2024 [April 18th, 2024]
- The Impact of Pediatric Plaque Psoriasis on Children and Caregivers - HMP Global Learning Network - April 18th, 2024 [April 18th, 2024]
- Guselkumab Led to Improvements Over Several Psoriatic Arthritis Disease Domains - MD Magazine - April 18th, 2024 [April 18th, 2024]
- Dual Diagnosing and Managing Psoriasis and Psoriatic Arthritis - The Dermatologist - April 18th, 2024 [April 18th, 2024]
- Etanercept Effective for Psoriasis, Rheumatic Disease Among Patients Extending Treatment After 12-Weeks - MD Magazine - February 9th, 2024 [February 9th, 2024]
- High Response Rates in Psoriasis With Oral IL-23 Inhibitor - Medpage Today - February 9th, 2024 [February 9th, 2024]
- Psoriasis and eczema have complex causes and consequences that researchers are seeking to uncover - Medical Xpress - February 9th, 2024 [February 9th, 2024]
- New Hope in Treatment of Plaque Psoriasis: Study Shows Promising Results - Medriva - February 9th, 2024 [February 9th, 2024]
- No Difference in Psoriasis Immune Response Despite Switch Between AVT02, Adalimumab - MD Magazine - February 9th, 2024 [February 9th, 2024]
- Oral IL-23 Receptor Antagonist Peptide Effective in PASI Reduction for Psoriasis - MD Magazine - February 9th, 2024 [February 9th, 2024]
- Breakthrough in Psoriasis Treatment: JNJ-77242113 Shows Promising Results - Medriva - February 9th, 2024 [February 9th, 2024]
- Promising Results from Phase II Trial of Oral Interleukin Inhibitor for Psoriasis Treatment - Medriva - February 9th, 2024 [February 9th, 2024]
- Promising Results from the FRONTIER 1 Trial - An Exploration of JNJ-77242113 in the Treatment of Moderate-to ... - Medriva - February 9th, 2024 [February 9th, 2024]
- Personal Experience with Psoriatic Arthritis and Atopic Dermatitis - Medriva - February 9th, 2024 [February 9th, 2024]
- Rising Cost of Stelara: Impact on Patients and Johnson & Johnson's Market Performance - Medriva - February 9th, 2024 [February 9th, 2024]
- Global Psoriatic Arthritis (PsA) Treatment Market to achieve a remarkable US$ 15.6 Billion by 2028, - PharmiWeb.com - February 9th, 2024 [February 9th, 2024]
- Tremfya potential highlighted by industry analyst GlobalData - The Pharma Letter - May 31st, 2023 [May 31st, 2023]
- Stress Leads to Increased Risk of Depression, Anxiety for Psoriasis ... - MD Magazine - May 31st, 2023 [May 31st, 2023]
- Janssen Announces Positive Results From Guselkumab Psoriatic ... - Dermatology Times - May 31st, 2023 [May 31st, 2023]
- Early Intervention with Secukinumab May Be Effective for Patients ... - MD Magazine - May 31st, 2023 [May 31st, 2023]
- VEGF-A Inhibition Downregulates Blood Vessel Area in Psoriasis - Dermatology Times - May 31st, 2023 [May 31st, 2023]
- Scratching the itch, Lynk Pharmaceuticals trialling ointment for ... - OutSourcing-Pharma.com - May 31st, 2023 [May 31st, 2023]
- Brepocitinib More Efficacious Than Placebo in Long-Term Psoriatic ... - Dermatology Times - May 31st, 2023 [May 31st, 2023]
- For Patients With Birthmarks, Psychosocial Interventions Improved ... - Dermatology Times - May 31st, 2023 [May 31st, 2023]
- Robert Hariri, MD: Natural Killer Cell Therapy Shows Remarkable ... - MD Magazine - May 31st, 2023 [May 31st, 2023]
- Nalbuphine ER Tablets Show Promise as Cough Therapy in ... - MD Magazine - May 31st, 2023 [May 31st, 2023]
- Benefit of Empagliflozin in HFpEF Consistent Regardless of Diuretic ... - MD Magazine - May 31st, 2023 [May 31st, 2023]
- selectION reports results from SAD stage of si-544 Phase Ib trial - Clinical Trials Arena - May 31st, 2023 [May 31st, 2023]
- No Link Observed Between Gastrointestinal Tract Surgery and New ... - MD Magazine - May 30th, 2023 [May 30th, 2023]
- Lynk doses first cohort in Phase Ib trial of psoriasis therapy - Clinical Trials Arena - May 30th, 2023 [May 30th, 2023]
- Metabolic Inflammation Contributes to Depression in Psoriatic Disease - Dermatology Times - May 30th, 2023 [May 30th, 2023]
- Encouraging Diversity and Inclusion for Patients With Psoriatic ... - MD Magazine - May 30th, 2023 [May 30th, 2023]
- The Weekly Roundup: May 22-26 - Dermatology Times - May 30th, 2023 [May 30th, 2023]
- Pediatric Psoriasis Market: A Study of the Industry's Key Applications ... - The Navajo Post - May 30th, 2023 [May 30th, 2023]
- Phototherapy Lamps Market are set to witness a CAGR of 5.8 ... - Digital Journal - May 30th, 2023 [May 30th, 2023]
- Celltrion seeks approval for Stelara biosimilar in EU - The Investor - May 30th, 2023 [May 30th, 2023]
- Peter Marinkovich, MD: FDA Approval of B-VEC Gene Therapy for ... - MD Magazine - May 30th, 2023 [May 30th, 2023]
- Nick Stucky, MD, Phd: Implications for Media Influence on Minoxidil ... - MD Magazine - May 30th, 2023 [May 30th, 2023]
- Tildrakizumab Linked With HRQOL Improvement in Psoriasis in a Real-World Setting - AJMC.com Managed Markets Network - May 18th, 2023 [May 18th, 2023]
- Clinical Utility of Deucravacitinib for the Management of Moderate to ... - Dove Medical Press - May 18th, 2023 [May 18th, 2023]
- Covid-19 and Psoriasis: Is there a link? - Dunya News - May 18th, 2023 [May 18th, 2023]
- Improvement Needed in Study Interventions to Better Skin Self ... - AJMC.com Managed Markets Network - May 18th, 2023 [May 18th, 2023]
- Reviva Pharmaceuticals Announces Intent to File an IND for Brilaroxazine in Psoriasis After Promising Preclinical Data - Marketscreener.com - May 18th, 2023 [May 18th, 2023]
- Adam Friedman, MD: Addressing Disparities in Care for Patients ... - MD Magazine - May 18th, 2023 [May 18th, 2023]
- Early-Infancy Meningitis Infection Linked With Increased Risk of ... - AJMC.com Managed Markets Network - May 18th, 2023 [May 18th, 2023]
- NOVN: Counting Down to PDUFA - Yahoo Finance - May 18th, 2023 [May 18th, 2023]
- Psoriatic Arthritis (PsA) Treatment Market is likely to register CAGR ... - Future Market Insights - May 18th, 2023 [May 18th, 2023]
- New campaign raises awareness of topical steroid withdrawal - Professional Beauty - May 18th, 2023 [May 18th, 2023]
- MoonLake Immunotherapeutics completes patient enrollment and randomization ahead of schedule in a Phase 2 trial of the Nanobody sonelokimab in... - February 2nd, 2023 [February 2nd, 2023]
- EVELO BIOSCIENCES, INC. : Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers, Other Events (form 8-K) -... - February 2nd, 2023 [February 2nd, 2023]
- 12 Ways to Treat Psoriasis at Home - Healthline - January 22nd, 2023 [January 22nd, 2023]
- DTC Advertising Of Prescription Drugs In The U.S. Often Promotes Products With Comparatively Low Therapeutic Value - Forbes - January 19th, 2023 [January 19th, 2023]
- Types of Psoriasis: Pictures, Symptoms and Treatments - Healthline - December 18th, 2022 [December 18th, 2022]
- Psoriasis Pathogenesis and Treatment - PMC - PubMed Central (PMC) - November 23rd, 2022 [November 23rd, 2022]
- Drug-Provoked Psoriasis: Is It Drug Induced or Drug Aggravated? - November 23rd, 2022 [November 23rd, 2022]
- Im a Dermatologist and These 7 Things Could Be Making Your Psoriasis Worse - Well+Good - October 19th, 2022 [October 19th, 2022]
- 'Worst time of the year for me to be covered in scabs': Amber Heard's Alleged Ex Cara Delevingne Revealed Her Psoriasis Struggle Made Kate Moss Scream... - October 19th, 2022 [October 19th, 2022]
- Psoriasis: What It Is, Symptoms, Causes, Types & Treatment - October 17th, 2022 [October 17th, 2022]
- What is psoriasis and which foods ease symptoms? - Evening Standard - October 17th, 2022 [October 17th, 2022]
- Chronic inflammatory diseases: what they are - Emergency Live International - October 17th, 2022 [October 17th, 2022]
- How remote care can deliver a step change in treatment for inflammatory skin conditions - PoliticsHome - October 17th, 2022 [October 17th, 2022]
- Probiotics Supplementation may Improve Symptoms of Hyperuricemia and Gout - Rheumatology Network - October 15th, 2022 [October 15th, 2022]
- Psoriasis Pathogenesis and Treatment - PubMed - October 2nd, 2022 [October 2nd, 2022]
- Best and Worst Drinks for Psoriasis - Everyday Health - October 2nd, 2022 [October 2nd, 2022]
- These Are the 10 Most Common Chronic Skin Conditionsand the Most Important Facts to Know About Them - Parade Magazine - October 2nd, 2022 [October 2nd, 2022]
- Survey Addresses Concerns Regarding Reproductive Healthcare Communication in Women with RA, PsA - Rheumatology Network - October 2nd, 2022 [October 2nd, 2022]
- Psoriasis Types, Symptoms & Causes | NIAMS - September 29th, 2022 [September 29th, 2022]
- What Is Psoriasis And Can It Be Treated? - Forbes - September 29th, 2022 [September 29th, 2022]
- Plaque Psoriasis Treated With Tildrakizumab Shown to be Effective in Real-World Settings - MD Magazine - September 29th, 2022 [September 29th, 2022]
- Alumis Announces Initiation of Patient Dosing in Phase 2 Clinical Trial of ESK-001 for the Treatment of Plaque Psoriasis - Business Wire - September 29th, 2022 [September 29th, 2022]
- 15 Items That Will Make Your Life With Psoriatic Arthritis Easier - BlackDoctor.Org - September 29th, 2022 [September 29th, 2022]
- Types of Psoriasis and Their Effects on the Immune System - Cureus - September 27th, 2022 [September 27th, 2022]
- MoonLake Immunotherapeutics to initiate global Phase 2 study of the Nanobody sonelokimab in patients with active psoriatic arthritis - BioSpace - September 27th, 2022 [September 27th, 2022]
- How diversity and inclusion continues to be incorporated in dermatology - PMLiVE - September 27th, 2022 [September 27th, 2022]
- Arcutis Announces Topline Results From ARRECTOR Pivotal Phase 3 Trial Of Roflumilast Foam 0.3% In Scalp A - Benzinga - September 27th, 2022 [September 27th, 2022]
- Psoriasis Treatment Market Size to Hit USD 51.24 Bn by 2030 - GlobeNewswire - August 15th, 2022 [August 15th, 2022]
- Ventyx Sees Initiation Of Mid-Stage Psoriasis Study In Q4 2022 Following Positive Data From Initial-Stage - Benzinga - August 15th, 2022 [August 15th, 2022]